Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process

$CLVT
EDP Services
Technology
Get the next $CLVT alert in real time by email

The partnership will see Iprova's suite of solutions integrated with IP management software IPfolio

LONDON, March 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Iprova, the world's first data-driven invention company and developer of state-of-the-art Artificial Intelligence-based technologies which augment and enhance the human ability to invent. This partnership will combine Iprova's product suite for collaboratively capturing, creating and refining inventive concepts with IPfolio, the industry-leading IP management software, enabling a smooth transition of inventions into the patent workflow.

The announcement also marks the release of the newly enhanced Invention Studio 3, Iprova's groundbreaking software that augments human ingenuity, empowering users to efficiently create valuable inventions. Hosted on Microsoft Azure, the new tool can be used by leading organizations around the world to create new inventions and generate novel intellectual property. The enhanced invention-creation tool is now integrated with IPfolio, providing a platform to centrally store, manage, and access the inventions created within Invention Studio 3.

Gordon Samson, President, Intellectual Property, Clarivate, said, "This exciting partnership will create a more cohesive and collaborative environment for inventors and attorneys to share ideas that can turn into high-quality, business aligned inventions. It's a first step in a journey to realizing a unique opportunity to improve the innovation economy by bridging the gap between knowledge and intellectual capital. At Clarivate, we think forward in our mission to provide unmatched support throughout the IP lifecycle, leveraging the latest technology. Through this partnership, we can support our clients earlier in the lifecycle, solidifying our role as an indispensable services partner and as the central hub for IP management."

"We are thrilled to partner with Clarivate to offer integrated, end-to-end solutions that transform the invention journey—from scoping and creation to patent filing and prosecution," said Julian Nolan, CEO and Founder of Iprova. "With the launch of our latest software, Invention Studio 3, we're empowering clients to efficiently capture, create, and refine high-value inventions. At Iprova, our goal is to democratize innovation, making it an accessible and universal activity across enterprises, while seamlessly integrating into existing workflows. Together with Clarivate, we make the invention workflow more robust, reliable, and efficient, reflecting the importance of the resulting intellectual assets for enterprises worldwide." 

Clarivate is committed to delivering purpose-driven technology to its customers in order to simplify and optimize IP management, enabling organizations worldwide to protect, manage, and leverage their IP assets in an increasingly competitive and global market.

To further drive innovation in IP management and decision making, Clarivate recently acquired Rowan Patents, an AI-driven patent drafting software designed to enable IP attorneys to create quality patents with speed and consistency. With the new AI-based capabilities from Rowan Patents and Iprova, Clarivate will serve as the central hub for IP management, providing new forms of support along the IP lifecycle.

About Clarivate

Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com 

Media contact:

Sofia Nogués,

Sr. External Communications Manager

Newsroom@clarivate.com

About Iprova

Iprova is pioneering the development of artificial intelligence and other technologies which augment and enhance the human ability to invent. Working with some of the world's best-known technology companies, our platform enables the products of tomorrow to be invented faster and more efficiently than has previously been possible, helping companies to compete more effectively.

Media contact:

Emma Stewart

Marketing Manager

estewart@iprova.com

SOURCE Clarivate Plc

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-partners-with-iprova-to-streamline-the-invention-creation-and-submission-process-302403618.html

SOURCE Clarivate Plc

Get the next $CLVT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$CLVT

DatePrice TargetRatingAnalyst
11/6/2024Outperform → Mkt Perform
William Blair
12/15/2023$8.00Equal Weight → Underweight
Wells Fargo
10/16/2023$10.00 → $8.50Hold → Buy
Jefferies
9/8/2023$8.00 → $7.00Equal Weight → Underweight
Barclays
8/25/2023$9.00 → $8.00Outperform → Sector Perform
RBC Capital Mkts
8/7/2023$10.00 → $6.00Neutral → Underperform
BofA Securities
8/4/2023$15.00 → $8.00Overweight → Equal Weight
Wells Fargo
6/13/2023$11.00Outperform
Oppenheimer
More analyst ratings

$CLVT
Press Releases

Fastest customizable press release news feed in the world

See more
  • Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process

    The partnership will see Iprova's suite of solutions integrated with IP management software IPfolio LONDON, March 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Iprova, the world's first data-driven invention company and developer of state-of-the-art Artificial Intelligence-based technologies which augment and enhance the human ability to invent. This partnership will combine Iprova's product suite for collaboratively capturing, creating and refining inventive concepts with IPfolio, the industry-leading IP management software, enabling a smooth transition of inventions into the patent

    $CLVT
    EDP Services
    Technology
  • Clarivate Reveals Top 100 Global Innovators 2025

    The Top 100 organizations generate $4.6 trillion USD in annual revenues, representing 4.4% of the global economy LONDON, March 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2025 ranked list of Top 100 Global Innovators – the organizations at the forefront of technology research and innovation worldwide. The Top 100 organizations prioritize innovation as a central part of their business strategy. Their investment levels in science, engineering, product design and problem-solving is, on average, 8

    $CLVT
    EDP Services
    Technology
  • Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

    New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing?, shedding light on the pharmaceutical industry's evolution in the region. The report explores critical challenges and opportunities, emphasizing the importance of strategic partnerships, local API production, and regulatory modernization to drive sustainable growth. Latin America's pharmaceuti

    $CLVT
    EDP Services
    Technology

$CLVT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$CLVT
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$CLVT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$CLVT
SEC Filings

See more

$CLVT
Leadership Updates

Live Leadership Updates

See more
  • Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

    Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

    $CLVT
    EDP Services
    Technology
  • Clarivate Names Bar Veinstein as President, Academia & Government

    Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

    $CLVT
    EDP Services
    Technology
  • Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

    Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

    $CLVT
    $CNTA
    EDP Services
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care

$CLVT
Financials

Live finance-specific insights

See more
  • Clarivate Reports Fourth Quarter and Full Year 2024 Results

    — Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON, Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024.

    $CLVT
    EDP Services
    Technology
  • Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025

    LONDON, Jan. 22, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the fourth quarter and full year 2024 before the market opens on Wednesday, February 19, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, February 19, 2025 to review the results. The webcast

    $CLVT
    EDP Services
    Technology
  • Clarivate Reports Third Quarter 2024 Results

    LONDON, Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9%Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6%Net loss of $65.6 million; Net loss per diluted share of $0.09Adjusted net income(1) of $134.1

    $CLVT
    EDP Services
    Technology

$CLVT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more